CAPS Stock UPDATES Capstone Therapeutics Corp (CAPS) 0.2350 10/23/2014

New Post Public Reply Private Reply Replies (0) Message Board

Oct 23, 2014 at 2:49 AM

Capstone Therapeutics Corp (CAPS) 0.2350 $CAPS

Capstone Therapeutics, Inc. - "AEM-28 Drug Class May Serve Larger Cardiovascular Markets"
ACCESSWIRE - Tue Oct 07, 7:51AM CDT
New York, NY / October 7, 2014 / Capstone Therapeutics (OTCQB: CAPS) today published a new blog post on The Chairman's Blog, written by the Company's Executive Chairman and Principal Executive Officer, John Holliman, III. TheChairmansBlog.com is an exclusive online media publication that enables key executive officers a unique platform to share insights about their company and industry trends.

Capstone Therapeutics Corp. Announces Digital Corporate Communication Channels
GlobeNewswire - Fri Sep 05, 12:09PM CDT
Capstone Therapeutics Corp. (OTCQB:CAPS) (the "Company" or "Capstone Therapeutics"

, a clinical stage biotechnology company developing a family of new peptide drugs, announced today its suite of online corporate communication channels to maintain on-going direct communication with stakeholders. The Company has launched official portals on social media channels including Facebook, Twitter, Google+ and The Chairman's Blog.

Capstone Therapeutics, Inc. - "A New Class of Cardiovascular Drug"
ACCESSWIRE - Fri Sep 05, 7:48AM CDT
New York, NY / September 5, 2014 / Capstone Therapeutics (OTCQB: CAPS) today published a new blog post on The Chairman's Blog, written by the Company's Executive Chairman and Principal Executive Officer, Jock Holliman. TheChairmansBlog.com is an exclusive online media publication that enables key executive officers a unique platform to share insights about their company and industry trends.

Capstone Therapeutics Announces Phase 1a Results for AEM-28 Showing Safety and Biomarker Efficacy Signals
GlobeNewswire - Tue Sep 02, 8:57AM CDT
Capstone Therapeutics (OTCQB:CAPS) ("the Company"

and its joint venture affiliate, LipimetiX Development, LLC ("JV"

, announced today the completion of dosing and patient follow-up for its investigational AEM-28 (Apo E mimetic peptide) Phase 1a human clinical trial in cholesterol and lipid reduction. The Medical Safety Committee, reviewing all safety-related aspects of the clinical trial, observed an acceptable safety profile. As a first-in-man study, the primary endpoint was safety; yet, biomarker efficacy measurements analyzing pharmacodynamics yielded trends favoring AEM-28 versus placebo in multiple cholesterol and lipid endpoints.

Capstone Therapeutics Will Provide an Operating Update and Announces Second Quarter 2014 Financial Results
GlobeNewswire - Thu Aug 14, 8:05AM CDT
Capstone Therapeutics (OTCQB:CAPS); (the "Company"

, today will hold a conference call and webcast to provide an operating update and announced financial results for the second quarter 2014.

Capstone Therapeutics Announces Second Quarter 2014 Financial Results and Operating Update Conference Call
GlobeNewswire - Wed Aug 06, 9:00AM CDT
Capstone Therapeutics (OTCQB:CAPS); (the "Company"

, will hold a conference call and webcast on Thursday, August 14, 2014 at 4:30 pm EDT. The call may be accessed at 877-303-2908 (U.S.), 408-427-3860 (outside U.S.); accompanying slides may be viewed by logging onto the Investors section of the Company's website, www.capstonethx.com. A replay will be available beginning August 14, 2014 at 7:30 pm EDT until midnight August 17, 2014, and may be accessed at 855-859-2056 (U.S.) or 404-537-3406 (outside U.S.) with conference ID 81563431.

Capstone Therapeutics Announces Operating Update Conference Call, Planned Initiation of AEM-28 Phase 1 Study and Fiscal Year 2013 Financial Results
GlobeNewswire - Thu Mar 27, 9:29AM CDT
Capstone Therapeutics (OTCQB:CAPS) ("the Company"

and its joint venture affiliate, LipimetiX Development, LLC ("JV"

, today will hold a conference call and webcast to provide an operating update, discuss the start of AEM-28 Phase 1 clinical studies and report financial results for the fiscal year 2013.

Capstone Therapeutics Announces Operating Update Conference Call
GlobeNewswire - Mon Mar 24, 1:30PM CDT
Capstone Therapeutics (OTCQB:CAPS); (the "Company"

, will hold a conference call and webcast on Thursday, March 27, 2014 at 4:30 pm EDT. The call may be accessed at 877-303-2908 (U.S.), 408-427-3860 (outside U.S.); accompanying slides may be viewed by logging onto the Investors section of the Company's website, www.capstonethx.com. A replay will be available beginning March 27, 2014 at 7:30 pm EDT until midnight March 30, 2014, and may be accessed at 855-859-2056 (U.S.) or 404-537-3406 (outside U.S.) with conference ID 12618657.

OTC Daily Alert Stock Watch - Capstone Therapeutics (OTCQB: CAPS)
WorldStockWire - Thu Aug 15, 9:00PM CDT
OTC Daily Alert tracks stocks daily and is pleased to offer features on public companies. Investors can receive FREE Stock Alerts and company news and profiles by visiting OTC Daily Alert at the following: http://www.otcdailyalert.com

Capstone Therapeutics to Hold Quarterly Operating Update Conference Call
GlobeNewswire - Wed Aug 07, 1:16PM CDT
Capstone Therapeutics (OTCQB:CAPS); (the "Company"

, will hold a conference call and webcast on Wednesday, August 14, 2013 at 4:30 pm EDT. The call may be accessed at 877-303-2908 (U.S.), 408-427-3860 (outside U.S.); accompanying slides may be viewed by logging onto the Investors section of the Company's website, www.capstonethx.com. A replay will be available beginning August 14, 2013 at 7:30 pm EDT until midnight August 17, 2013 and may be accessed at 855-859-2056 (U.S.) or 404-537-3406 (outside U.S.) with conference ID 27383573.

Capstone Therapeutics Will Provide an Operating Update and Announces First Quarter 2013 Financial Results
GlobeNewswire - Wed May 15, 8:30AM CDT
Capstone Therapeutics (OTCQB:CAPS); (the "Company"

, today will hold a conference call and webcast to provide an operating update and announced financial results for the first quarter 2013.

Capstone Therapeutics to Hold Operating Update Conference Call
GlobeNewswire - Wed May 08, 8:00AM CDT
Capstone Therapeutics (OTCQB:CAPS); (the "Company"

, will hold a conference call and webcast on Wednesday, May 15, 2013 at 4:30 pm EDT. The call may be accessed at 877-303-2908 (U.S.), 408-427-3860 (outside U.S.); accompanying slides may be viewed by logging onto the Investors section of the Company's website, www.capstonethx.com. A replay will be available beginning May 15, 2013 at 7:30 pm EDT until midnight May 18, 2013 and may be accessed at 855-859-2056 (U.S.) or 404-537-3406 (outside U.S.) with conference ID 68894502.

Capstone Therapeutics Will Provide an Operating Update and Announces 2012 Financial Results
GlobeNewswire - Thu Mar 14, 7:15AM CDT
Capstone Therapeutics (OTCQB:CAPS); (the "Company"

, today will hold a conference call and webcast to provide an operating update and 2012 financial results.

OTC Signal Daily Stock Watch - Capstone Therapeutics (CAPS)
WorldStockWire - Mon Dec 17, 10:45AM CST
OTC Signal tracks stocks daily and is pleased to offer its stock alerts. Investors can receive FREE Stock Alerts and company news and profiles by visiting OTC Signal at the following: http://www.otcsignal.com

Newer

Older

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Stellus Capital Set to Unveil Q3 Results: Key Details

Stellus Capital's Upcoming Financial Reveal: Stakes and Details November's not just bringing the cold breezes, folks; it's also ushering in the much-anticipated financial digits of Stellus Capital Investment Corporation's third quarter of 2026. Mark your calendars for November 9, after the stock market wraps up, when Stellus will drop its operational performance stats for...

Gorenje's Limited UAE Offer: A Gift for Cooking Enthusiasts

Been around the block long enough to know a promo worth a second glance when I see one, especially in the home appliance game. Gorenje, a gem under Hisense's umbrella, is stirring up the UAE kitchen scene. Here's why this matters. Cooking Made Fun, Not a Chore If you've ever cursed at a stovetop, you'll know cooking ain't everyone's blast of fresh air. Gorenje gets it....

Defense Contractors Eye Larger Backlogs Amid Funding Uncertainty

Playing Chicken with Federal Deadlines We've got ourselves a situation where defense contractors are juggling bigger backlogs while the clock ticks down to a looming federal funding deadline on December 11. If this sounds like a high-stakes game of chicken, it's because it is. No one knows if Congress will stitch things up before the stopgap funding dries up. Hell, maybe...

Historic Surge: Women Veterans Join 120th Congress

The Winds of Change Are Blowing Through Washington It looks like the face of Congress is getting a combat-ready makeover with the latest election results. Veterans are stepping up to the plate, claiming at least 79 seats in the 120th Congress, with a historic presence of women veterans making waves. Yeah, we're talking about 11 women veterans hitting the halls of power,...

Pearson-Westermann Partnership Boosts English Skills in Germany

Revolutionizing English Education in Germany Alright, folks, here's the scoop for all you with a toe in education and workforce development. Pearson and Westermann are shaking hands to tackle one of the biggest skills needed in Germany: English proficiency. This might sound like a dry move on the surface, but trust me, it's a game-changer for students and job seekers...

Lemonade Renters Insurance Expands Nationwide with MN

Lemonade Finally Goes Full Circle Shake things up and ask yourself: When was the last time an insurance company made news for completing something big? Now, Lemonade (NYSE: LMND) just landed itself a headline by launching its renters insurance in Minnesota. With this move, it’s rounded off its offer across all 50 states plus Washington, D.C. Hitting that nationwide...

Speakeasy Dispensary Brings Medical Cannabis to Maysville

New Chapter for Maysville: Speakeasy Opens Doors Normally, you'd think of medical cannabis expansions as dry numbers and policies, but with Speakeasy Dispensary making its mark in Maysville, it's not just about business; it's a service to the community. Nestled into 317 W 2nd St, this is more than a simple retail spot. It's about bringing medical options straight to the...

Mazu Forum: Bridging Cultures and Marine Safety

The 11th Global Mazu Culture Forum kicked off on November 1 in Putian City, Fujian Province—smack dab on the historical Meizhou Island. This ain’t just another talk-fest; it's a melting pot of ideas and achievements packaged with cultural flair and some serious tech muscle. Nestled in China's southeast, Meizhou Island serves as the heartland for Mazu culture, a beacon...

Direct Connection Unleashes Powerful HEMI V8 Engine Programs

HEMI V8 Legacy Reinvention at SEMA 2026 If you're the sort who gets their hands greasy restoring or revamping classic muscle, well, Direct Connection just made your life a whole lot easier. Stellantis' performance arm pulled the wraps off not just one, but six new HEMI V8 crate engine packages at the 2026 SEMA Show. Now, that's how you turn heads in Vegas. A New...

Tea Extract Market Expansion: $4.7B by 2031 Forecast

The Surging Demand for Tea Extracts The tea extract market's carving out quite a niche for itself. From $3.22 billion in 2026, it's primed to scale up to a cool $4.70 billion by 2031. That's a steady 7.9% growth rate, and it's just fueled by the booming demand for all things natural and health-oriented. Natural and Functional: Key Industry Drivers Consumers these days...